Comprehensive Transcriptome Analysis Expands lncRNA Functional Profiles in Breast Cancer

Area of Science:

• Genomics
• Molecular Biology
• Cancer Research

Background:

• Breast cancer is a complex, heterogeneous disease with variable patient outcomes despite similar clinical staging.
• Molecular genetic alterations significantly influence prognosis and treatment response.
• Long non-coding RNAs (lncRNAs) are key regulators of gene expression and cellular processes, vital for breast cancer subtyping.

Purpose of the Study:

• To develop a framework for identifying novel lncRNAs in breast cancer.
• To investigate the biological functions, regulatory mechanisms, and clinical relevance of these newly identified lncRNAs.
• To explore the association of lncRNA expression with breast cancer subtypes, immune response, and progression.

Main Methods:

• Development of a modular framework for lncRNA identification.
• Application of the framework to a breast cancer cohort to discover novel lncRNAs.
• Analysis of genomic and chromatin features, associated genes, and regulatory networks.
• Correlation of lncRNA expression patterns with PAM50 subtyping, immune response, and immune checkpoint genes.

Main Results:

• Identification of previously unannotated lncRNAs in breast cancer.
• Elucidation of the regulatory roles of novel lncRNAs in gene expression and breast cancer networks.
• Demonstration of links between lncRNA expression and hormone response, immune infiltration, and cancer progression.
• Association of lncRNA expression with immune checkpoint genes.

Conclusions:

• Novel and annotated lncRNAs are integral to breast cancer biology, influencing gene expression and regulatory networks.
• These lncRNAs are associated with key aspects of breast cancer, including hormone response and immune modulation.
• The comprehensive analysis provides deeper understanding of breast cancer heterogeneity and suggests potential therapeutic strategies.